Prem K. Premsrirut, Ph.D.

Affiliations: 
2010 Genetics Stony Brook University, Stony Brook, NY, United States 
Area:
Genetics, Oncology, Molecular Biology
Google:
"Prem Premsrirut"

Parents

Sign in to add mentor
Scott Lowe grad student 2010 SUNY Stony Brook
 (Spatial, temporal and reversible regulation of endogenous genes in vivo using RNA interference.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Premsrirut PK, Wang C, Yang Y, et al. (2018) Abstract 5106: CRISPR/Cas9-based development of RNAi rat models for drug discovery Cancer Research. 78: 5106-5106
Pelossof R, Fairchild L, Huang CH, et al. (2017) Prediction of potent shRNAs with a sequential classification algorithm. Nature Biotechnology
Wolter K, Pesic M, Klotz S, et al. (2017) Abstract LB-335: Induction of Ribosomal Checkpoint Induced Senescence (RCIS) for the treatment of liver cancer Cancer Research. 77
Premsrirut P, Martin G, Dow L, et al. (2016) RNAi and CRISPR/Cas9 based in vivo models for drug discovery European Journal of Cancer. 61: S208
Premsrirut PK, Martin G, Dow L, et al. (2016) Abstract 4188: RNAi and CRISPR/Cas9 basedin vivomodels for drug discovery Cancer Research. 76: 4188-4188
Mullenders J, Aranda-Orgilles B, Lhoumaud P, et al. (2015) Cohesin loss alters adult hematopoietic stem cell homeostasis, leading to myeloproliferative neoplasms. The Journal of Experimental Medicine
Li X, Chuang PY, D'Agati VD, et al. (2015) Nephrin Preserves Podocyte Viability and Glomerular Structure and Function in Adult Kidneys. Journal of the American Society of Nephrology : Jasn
Premsrirut PK, Wang C, Yang Y, et al. (2015) Abstract B37: RNAi and CRISPR/Cas9-based in vivo models for drug discovery Cancer Research. 78: 4188-4188
Premsrirut PK, Fellmann C. (2015) Abstract LB-078: RNAi and CRISPR/Cas9-based in vivo models for drug discovery Molecular and Cellular Biology
Chuang PY, Xu J, Dai Y, et al. (2014) In vivo RNA interference models of inducible and reversible Sirt1 knockdown in kidney cells. The American Journal of Pathology. 184: 1940-56
See more...